These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32691403)

  • 21. Hürthle cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy.
    Vattimo A; Bertelli P; Cintorino M; Burroni L; Volterrani D; Vella A; Lazzi S
    J Nucl Med; 1998 May; 39(5):822-5. PubMed ID: 9591583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile.
    Földes I; Lévay A; Stotz G
    Eur J Nucl Med; 1993 Apr; 20(4):330-3. PubMed ID: 8387921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy.
    Fujie S; Okumura Y; Sato S; Akaki S; Katsui K; Himei K; Takemoto M; Kanazawa S
    Acta Med Okayama; 2005 Jun; 59(3):99-107. PubMed ID: 16049563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technetium-99m-MIBI scintigraphy of thyroid nodules in an endemic goiter area.
    Kresnik E; Gallowitsch HJ; Mikosch P; Gomez I; Lind P
    J Nucl Med; 1997 Jan; 38(1):62-5. PubMed ID: 8998152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
    Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
    Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology.
    Giovanella L; Suriano S; Maffioli M; Ceriani L; Spriano G
    Head Neck; 2010 May; 32(5):607-11. PubMed ID: 19693945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiating malignant from benign thyroid nodules with indeterminate cytology by
    Campennì A; Siracusa M; Ruggeri RM; Laudicella R; Pignata SA; Baldari S; Giovanella L
    Sci Rep; 2017 Jul; 7(1):6147. PubMed ID: 28733644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors.
    Nakahara H; Noguchi S; Murakami N; Hoshi H; Jinnouchi S; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
    J Nucl Med; 1996 Jun; 37(6):901-4. PubMed ID: 8683308
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Huang Z; Lou C
    J Int Med Res; 2019 Feb; 47(2):836-845. PubMed ID: 30556441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of the incidental thyroid gland uptake during Tc-99m MIBI myocardial perfusion scintigraphy.
    Karacavus S; Ede H; Sarikaya S; Delibas N; Kaya E; Erbay AR
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2781-5. PubMed ID: 26241530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tc-99m MIBI scintigraphic detection of metastatic insular thyroid carcinoma.
    Zak IT; Seabold JE; Gurll NJ
    Clin Nucl Med; 1995 Jan; 20(1):31-6. PubMed ID: 7895433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma probe-guided resection and scanning with TC-99m MIBI of a local recurrence of follicular thyroid carcinoma.
    Boz A; Arici C; Güngör F; Yildiz A; Colak T; Karayalçin B
    Clin Nucl Med; 2001 Oct; 26(10):820-2. PubMed ID: 11564916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of thyroid nodules for malignancy using 99Tcm-sestamibi.
    Sundram FX; Mack P
    Nucl Med Commun; 1995 Aug; 16(8):687-93. PubMed ID: 7491182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tc-99m MIBI scintigraphy in tall cell variant of papillary thyroid carcinoma with negative radioiodine scan.
    Kaya M; Cermik TF
    Clin Nucl Med; 2008 Sep; 33(9):615-8. PubMed ID: 18716510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discordant uptake of Tl-201 and Tc-99m MIBI in a patient with follicular adenoma.
    Erdil TY; Turoğlu HT
    Ann Nucl Med; 2000 Apr; 14(2):135-8. PubMed ID: 10830533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical importance of technetium-99m-methoxyisobutylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results.
    Küçük NO; Külak HA; Aras G
    Ann Nucl Med; 2006 Jul; 20(6):393-7. PubMed ID: 16922467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [High retention of (99m)Tc-MIBI in delayed phase as a pitfall in the combined parathyroid-thyroid scintigraphy].
    Verdú J; Lizárraga C; Clavel J; Prata I; Calbo J; Pomares F
    Rev Esp Med Nucl; 2010; 29(5):251-3. PubMed ID: 20381207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of thyroid nodules using technetium-99m sestamibi.
    Sundram FX; Mack PO
    Ann Acad Med Singap; 1993 Jul; 22(4):560-2. PubMed ID: 8257058
    [No Abstract]   [Full Text] [Related]  

  • 39. MIBI and thyroid tumors.
    Kresnik E; Gallowitsch HJ; Mikosch P; Lind P
    J Nucl Med; 1997 Sep; 38(9):1501. PubMed ID: 9293819
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of hepatic metastasis from medullary thyroid cancer with Tc-99m-MIBI scintigraphy in a patient with Sipple's syndrome.
    Sato S; Okumura Y; Tamizu A; Maki K; Akaki S; Takeda Y; Kanazawa S; Hiraki Y
    Ann Nucl Med; 2001 Oct; 15(5):443-6. PubMed ID: 11758951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.